Breaking News: Elly De La Cruz Releases Medical and PEDs Report Amid Scrutiny
Cincinnati, OH — May 29, 2025
In a surprising and bold move, Cincinnati Reds rising star Elly De La Cruz has publicly released his complete medical and performance-enhancing drugs (PEDs) testing report in response to growing speculation surrounding his rapid ascent in Major League Baseball.
The 23-year-old phenom, known for his electric speed, power, and athleticism, shared the documents via his official social media accounts early Thursday morning. The report includes detailed medical evaluations, bloodwork, and PED testing results dating back to his time in the minor leagues.
“I have nothing to hide,” De La Cruz wrote in a statement accompanying the report. “Every test I’ve taken has come back clean. I respect this game, and I’ve worked my entire life to play it the right way. I’m releasing this report to put any doubts to rest.”
The move follows a wave of online speculation after De La Cruz’s jaw-dropping performances early in the 2025 season, where he’s been on a historic pace in both stolen bases and home runs. While MLB has not announced any formal investigations, the noise from commentators and fans prompted De La Cruz to take action.
According to the published report, De La Cruz has passed all mandatory and random PED tests administered by MLB, including tests for anabolic steroids, stimulants, and other banned substances. The documentation appears to be verified by independent medical professionals.
Team officials and teammates have rallied around De La Cruz. “Elly’s work ethic is second to none,” Reds manager David Bell said. “We’ve watched him grow into an elite player, and this shows his character and leadership.”
MLB has yet to comment officially on the release, but early reaction from around the league has been largely positive, with many praising De La Cruz’s transparency.
As the season progresses, De La Cruz remains focused on leading the Reds and silencing any remaining doubters—with his performance and now, with proof.
Leave a Reply